L―门冬酸氨氯地平片联合阿托伐他汀钙片治疗65例老年高血压合并冠心病疗效观察.docVIP

L―门冬酸氨氯地平片联合阿托伐他汀钙片治疗65例老年高血压合并冠心病疗效观察.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
L―门冬酸氨氯地平片联合阿托伐他汀钙片治疗65例老年高血压合并冠心病疗效观察

L―门冬酸氨氯地平片联合阿托伐他汀钙片治疗65例老年高血压合并冠心病疗效观察   摘 要 目的:探讨L-门冬酸氨氯地平片联合阿托伐他汀钙片治疗老年高血压合并冠心病的疗效。方法:收集2010年6月-2012年6月我院收治的老年高血压合并冠心病患者130例,按随机数字法分为观察组和对照组,每组65例。观察两组患者血压、心绞痛变化及不良反应,并评价疗效。结果:观察组治疗后SBP、DBP、心绞痛发作次数均显著低于对照组,总有效率为90.76%(59/65),高于对照组的78.46%(51/65)。结论:服用L-门冬酸氨氯地平片联合阿托伐他汀钙片的观察组较服用硝苯地平片,血脂康胶囊的对照组,调脂又降压,改善心功能,疗效更好,不良反应少。   关键词 L-门冬酸氨氯地平片 阿托伐他汀钙片 高血压 冠心病   中图分类号:R972; R969.4 文献标识码:B 文章编号:1006-1533(2013)11-0022-03   Effect of combination of L-aspartic acid amlodipine   tablets with atorvastatin calcium tablets in the treatment of   65 elderly patients with hypertension and coronary heart disease   CAO Baolin, LIU Xingang   (Community Health Center of Tianlin Street in Xuhui district, Shanghai 200233, China)   ABSTRACT Objective: To investigate the effect of L-aspartic acid amlodipine tablets and atorvastatin calcium tablets on the treatment of elderly patients with hypertension and coronary heart disease. Methods: One hundred and thirty cases of elderly patients treated in our hospital from June 2010 to June 2012 were divided into an observation group and a control group with 65 cases each based on the random digital act. Patients were treated with atorvastatin in the control group or L-aspartic acid amlodipine tablets plus atorvastatin calcium tablets in the observation group. The blood pressure, angina changes and adverse reactions were observed and their efficacy was evaluated. Results: After treatment, the SBP, DBP, angina attack frequency of patients were significantly reduced in the observation group than in the control group (P0.05). The total effective rate was 90.76%(59/65)in the observation group and 78.46%(51/65)in the control group and their difference was statistically significant (P0.05). Conclusion: Combination therapy of L-aspartic acid amlodipine tablets with atorvastatin calcium tablets can reduce lipid and blood pressure and improve heart function with a higher efficacy and fewer adverse reactions as compared with monotherapy of atorvastatin.

文档评论(0)

3471161553 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档